(Q35043730)

6 August 2017

1 reference

title

A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

6 August 2017

main subject

1 reference

1 reference

1 reference

1 reference

Michael F Costello

1

1 reference

6 August 2017

John A Eden

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

6 August 2017

published in

Fertility and Sterility

1 reference

6 August 2017

volume

79

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

1-13

1 reference

Polycystic ovary syndrome

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Polycystic ovary syndrome: a changing perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Insulin and the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Insulin action in the normal and polycystic ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Polycystic ovary syndrome: clinical perspectives and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Clomiphene citrate in the twenty-first century.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Optimizing ovulation induction in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Prediction of the effect of metformin treatment in patients with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Insulin resistance in clomiphene responders and non-responders with polycystic ovarian disease and therapeutic effects of metformin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

The existence of publication bias and risk factors for its occurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904554-5

10.1016/S0015-0282(02)04554-5

7 January 2021

Identifiers

DOI

1 reference

6 August 2017

1 reference